journal
MENU ▼
Read by QxMD icon Read
search

Chinese Journal of Cancer

journal
https://www.readbyqxmd.com/read/27894338/erratum-to-chromatin-remodeling-factor-lsh-affects-fumarate-hydratase-as-a-cancer-driver
#1
Shuang Liu, Yong-Guang Tao
No abstract text is available yet for this article.
November 28, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27887636/development-and-validation-of-a-nomogram-for-predicting-the-survival-of-patients-with-non-metastatic-nasopharyngeal-carcinoma-after-curative-treatment
#2
Wenhua Liang, Guanzhu Shen, Yaxiong Zhang, Gang Chen, Xuan Wu, Yang Li, Anchuan Li, Shiyang Kang, Xi Yuan, Xue Hou, Peiyu Huang, Yan Huang, Hongyun Zhao, Ying Tian, Chong Zhao, Li Zhang
BACKGROUND: The TNM staging system is far from perfect in predicting the survival of individual cancer patients because only the gross anatomy is considered. The survival rates of the patients who have the same TNM stage disease vary across a wide spectrum. This study aimed to develop a nomogram that incorporates other clinicopathologic factors for predicting the overall survival (OS) of non-metastatic nasopharyngeal carcinoma (NPC) patients after curative treatments. METHODS: We retrospectively collected the clinical data of 1520 NPC patients who were diagnosed histologically between November 2000 and September 2003...
November 25, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27887628/implications-of-vessel-co-option-in-sorafenib-resistant-hepatocellular-carcinoma
#3
Elizabeth A Kuczynski, Robert S Kerbel
The reason why tumors generally have a modest or transient response to antiangiogenic therapy is not well understood. This poses a major challenge for sorafenib treatment of advanced hepatocellular carcinoma (HCC) where alternate therapies are lacking. We recently published a paper entitled "Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma" in the Journal of the National Cancer Institute, providing a potential explanation for this limited benefit...
November 25, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27852288/the-clinical-association-of-programmed-cell-death-protein-4-pdcd4-with-solid-tumors-and-its-prognostic-significance-a-meta-analysis
#4
John Zeng Hong Li, Wei Gao, Wai-Kuen Ho, Wen Bin Lei, William Ignace Wei, Jimmy Yu-Wai Chan, Thian-Sze Wong
BACKGROUND: Programmed cell death protein 4 (PDCD4) is a novel tumor suppressor protein involved in programmed cell death. Its association with cancer progression has been observed in multiple tumor models, but evidence supporting its association with solid tumors in humans remains controversial. This study aimed to determine the clinical significance and prognostic value of PDCD4 in solid tumors. METHODS: A systematic literature review was performed to retrieve publications with available clinical information and survival data...
November 16, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27852284/prognostic-value-and-predictive-threshold-of-tumor-volume-for-patients-with-locally-advanced-nasopharyngeal-carcinoma-receiving-intensity-modulated-radiotherapy
#5
Yu-Xiang He, Ying Wang, Peng-Fei Cao, Lin Shen, Ya-Jie Zhao, Zi-Jian Zhang, Deng-Ming Chen, Tu-Bao Yang, Xin-Qiong Huang, Zhou Qin, You-Yi Dai, Liang-Fang Shen
BACKGROUND: Gross target volume of primary tumor (GTV-P) is very important for the prognosis prediction of patients with nasopharyngeal carcinoma (NPC), but it is unknown whether the same is true for locally advanced NPC patients treated with intensity-modulated radiotherapy (IMRT). This study aimed to clarify the prognostic value of tumor volume for patient with locally advanced NPC receiving IMRT and to find a suitable cut-off value of GTV-P for prognosis prediction. METHODS: Clinical data of 358 patients with locally advanced NPC who received IMRT were reviewed...
November 16, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27846913/induction-chemotherapy-for-locoregionally-advanced-nasopharyngeal-carcinoma
#6
Wen-Fei Li, Lei Chen, Ying Sun, Jun Ma
The value of adding induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) for the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. In our recent article entitled "Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial" published in the Lancet Oncology, we reported the results of a phase III, multicenter, randomized controlled trial comparing cisplatin, 5-fluorouracil, and docetaxel (TPF) IC plus CCRT versus CCRT alone in patients with T3-4N1/TxN2-3M0 NPC (ClinicalTrials...
November 15, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27846874/treatment-implications-of-posterior-fossa-ependymoma-subgroups
#7
Vijay Ramaswamy, Michael D Taylor
Posterior fossa ependymoma comprises two distinct molecular entities, ependymoma_posterior fossa A (EPN_PFA) and ependymoma_posterior fossa B (EPN_PFB), with differentiable gene expression profiles. As yet, the response of the two entities to treatment is unclear. To determine the relationship between the two molecular subgroups of posterior fossa ependymoma and treatment, we studied a cohort of 820 patients with molecularly profiled, clinically annotated posterior fossa ependymomas. We found that the strongest predictor of poor outcome in patients with posterior fossa ependymoma across the entire age spectrum was molecular subgroup EPN_PFA, which was recently reported in the paper entitled "Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis" in the Journal of Clinical Oncology...
November 15, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27793187/a-combination-therapy-for-kras-mutant-lung-cancer-by-targeting-synthetic-lethal-partners-of-mutant-kras
#8
Xiufeng Pang, Mingyao Liu
The KRAS gene is frequently mutated in multiple cancer types, but it fell off the drug discovery radar for many years because of its inherent "undruggable" structure and undefined biological properties. As reported in the paper entitled "Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK" in Nature Communications, we performed a synthetic lethal screening with a combinatorial strategy on a panel of clinical drugs; we found that combined inhibition of polo-like kinase 1 and RhoA/Rho kinase markedly suppressed tumor growth in mice...
October 28, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27733208/abo-blood-group-is-a-predictor-of-survival-in-patients-with-laryngeal-cancer
#9
Ting Jin, Pei-Jing Li, Xiao-Zhong Chen, Wei-Han Hu
BACKGROUND: Whether the ABO blood group is associated with the survival of patients with laryngeal cancer remains unknown. The purpose of this study was to investigate the association between the ABO blood group and clinicopathologic characteristics of patients with laryngeal cancer and assess whether the ABO blood group was associated with prognosis. METHODS: We analyzed the records of 1260 patients with laryngeal cancer who underwent curative treatment at Sun Yat-sen University Cancer Center between January 1993 and December 2009...
October 13, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27733189/what-do-oncologists-need-to-know-about-biosimilar-products
#10
REVIEW
Linda K S Leung, Kevin Mok, Calvin Liu, Stephen L Chan
Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of "comparability" or "no clinically meaningful differences" as compared to its reference biologic product. Biosimilar products for erythropoietin, granulocyte colony-stimulating factor, trastuzumab, and rituximab are already available, and the regulatory processes in various countries are constantly evolving...
October 13, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27729091/radiation-induced-osteosarcoma-of-the-maxilla-and-mandible-after-radiotherapy-for-nasopharyngeal-carcinoma
#11
Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng, Xue-Kui Liu
BACKGROUND: The increasing incidence of radiation-induced osteosarcoma of the maxilla and mandible (RIOSM) has become a significant problem that can limit long-term survival. The purpose of this study was to analyze the association of clinicopathologic characteristics with treatment outcomes and prognostic factors of patients who developed RIOSM after undergoing radiotherapy for nasopharyngeal carcinoma (NPC). METHODS: We reviewed the medical records of 53,760 NPC patients admitted to Sun Yat-sen University Cancer Center during the period August 1964 to August 2012...
October 12, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27624700/new-risk-factors-and-new-tendency-for-central-nervous-system-relapse-in-patients-with-diffuse-large-b-cell-lymphoma-a-retrospective-study
#12
Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, Zhong-Jun Xia
BACKGROUND: In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (CNS) relapse is uncommon but is nearly always fatal. This study aimed to determine the risk factors for CNS relapse in DLBCL patients and to evaluate the efficacy of rituximab and intrathecal chemotherapy prophylaxis for CNS relapse reduction. METHODS: A total of 511 patients with newly diagnosed DLBCL treated at the Sun Yat-sen University Cancer Center between January 2003 and December 2012 were included in the study...
September 13, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27581465/gastric-cancer-current-and-evolving-treatment-landscape
#13
REVIEW
Weijing Sun, Li Yan
Gastric (including gastroesophageal junction) cancer is the third leading cause of cancer-related death in the world. In China, an estimated 420,000 patients were diagnosed with gastric cancer in 2011, ranking this malignancy the second most prevalent cancer type and resulting in near 300,000 deaths. The treatment landscape of gastric cancer has evolved in recent years. Although systemic chemotherapy is still the mainstay treatment of metastatic disease, the introduction of agents targeting human epidermal growth factor receptor 2 and vascular endothelial growth factor/vascular endothelia growth factor receptor has brought this disease into the molecular and personalized medicine era...
August 31, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27507261/overweight-obese-status-associates-with-favorable-outcome-in-patients-with-metastatic-nasopharyngeal-carcinoma-a-10-year-retrospective-study
#14
Wang Li, Lu-Jun Shen, Tao Chen, Xu-Qi Sun, Ying Zhang, Ming Wu, Wan-Hong Shu, Chen Chen, Chang-Chuan Pan, Yun-Fei Xia, Pei-Hong Wu
BACKGROUND: Although the prognostic impact of body mass index (BMI) in patients with non-metastatic nasopharyngeal carcinoma (NPC) had been extensively studied, its effect among metastatic NPC patients remains unknown. The purpose of this study was to evaluate the prognostic effect of BMI in patients with metastatic NPC. METHODS: We retrospectively studied 819 patients who were diagnosed with distant metastasis from NPC and received treatment between 1998 and 2007...
August 9, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27473869/chromatin-remodeling-factor-lsh-affects-fumarate-hydratase-as-a-cancer-driver
#15
Shuang Liu, Yong-Guang Tao
Cancer metabolism and epigenetic alteration are two critical mechanisms for tumorigenesis and cancer progression; however, the dynamic interplay between them remains poorly understood. As reported in the article entitled "Chromatin remodeling factor LSH drives cancer progression by suppressing the activity of fumarate hydratase," which was recently published in Cancer Research, our group examined the physiological role of lymphocyte-specific helicase (LSH) in nasopharyngeal carcinoma (NPC) by focusing on cancer progression and the tricarboxylic acid cycle...
July 30, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27460019/evolution-of-gastric-surgery-techniques-and-outcomes
#16
REVIEW
Hironori Shiozaki, Yusuke Shimodaira, Elena Elimova, Roopma Wadhwa, Kazuki Sudo, Kazuto Harada, Jeannelyn S Estrella, Prajnan Das, Brian Badgwell, Jaffer A Ajani
Surgical management of gastric cancer improves survival. However, for some time, surgeons have had diverse opinions about the extent of gastrectomy. Researchers have conducted many clinical studies, making slow but steady progress in determining the optimal surgical approach. The extent of lymph node dissection has been one of the major issues in surgery for gastric cancer. Many trials demonstrated that D2 dissection resulted in greater morbidity and mortality than D1 dissection. However, long-term outcomes demonstrated that D2 dissection resulted in longer survival than D1 dissection...
July 26, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27443349/genetic-alteration-and-mutation-profiling-of-circulating-cell-free-tumor-dna-cfdna-for-diagnosis-and-targeted-therapy-of-gastrointestinal-stromal-tumors
#17
REVIEW
Weixin Yan, Aiguo Zhang, Michael J Powell
Gastrointestinal stromal tumors (GISTs) have been recognized as a biologically distinctive type of tumor, different from smooth muscle and neural tumors of the gastrointestinal tract. The identification of genetic aberrations in proto-oncogenes that drive the growth of GISTs is critical for improving the efficacy of cancer therapy by matching targeted drugs to specific mutations. Research into the oncogenic mechanisms of GISTs has found that these tumors frequently contain activating gene mutations in either platelet-derived growth factor receptor A (PDGFRA) or a receptor tyrosine protein associated with a mast cell growth factor receptor encoded by the KIT gene...
July 21, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27357728/a-model-to-predict-the-risk-of-lethal-nasopharyngeal-necrosis-after-re-irradiation-with-intensity-modulated-radiotherapy-in-nasopharyngeal-carcinoma-patients
#18
Ya-Hui Yu, Wei-Xiong Xia, Jun-Li Shi, Wen-Juan Ma, Yong Li, Yan-Fang Ye, Hu Liang, Liang-Ru Ke, Xing Lv, Jing Yang, Yan-Qun Xiang, Xiang Guo
BACKGROUND: For patients with nasopharyngeal carcinoma (NPC) who undergo re-irradiation with intensity-modulated radiotherapy (IMRT), lethal nasopharyngeal necrosis (LNN) is a severe late adverse event. The purpose of this study was to identify risk factors for LNN and develop a model to predict LNN after radical re-irradiation with IMRT in patients with recurrent NPC. METHODS: Patients who underwent radical re-irradiation with IMRT for locally recurrent NPC between March 2001 and December 2011 and who had no evidence of distant metastasis were included in this study...
June 29, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27233623/emerging-molecular-classifications-and-therapeutic-implications-for-gastric-cancer
#19
REVIEW
Tao Chen, Xiao-Yue Xu, Ping-Hong Zhou
Gastric cancer (GC) is a highly aggressive and life-threatening malignancy. Even with radical surgical removal and front-line chemotherapy, more than half of GCs locally relapse and metastasize at a distant site. The dismal outcomes reflect the ineffectiveness of a one-size-fits-all approach for a highly heterogeneous disease with diverse etiological causes and complex molecular underpinnings. The recent comprehensive genomic and molecular profiling has led to our deepened understanding of GC. The emerging molecular classification schemes based on the genetic, epigenetic, and molecular signatures are providing great promise for the development of more effective therapeutic strategies in a more personalized and precise manner...
May 27, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/26956022/prospective-single-center-cohort-study-analyzing-the-efficacy-of-complete-laparoscopic-resection-on-recurrent-hepatocellular-carcinoma
#20
Jie Zhang, Zhong-Guo Zhou, Zhong-Xi Huang, Ke-Li Yang, Jian-Cong Chen, Jin-Bin Chen, Li Xu, Min-Shan Chen, Yao-Jun Zhang
BACKGROUND: Laparoscopic hepatectomy is increasingly being used to treat hepatocellular carcinoma (HCC). However, few studies have examined the treatment of recurrent HCC in patients who received a prior hepatectomy. The present prospective study compared the clinical efficacy of laparoscopic surgery with conventional open surgery in HCC patients with postoperative tumor recurrence. METHODS: We conducted a prospective study of 64 patients, all of whom had undergone open surgery once before, who were diagnosed with recurrent HCC between June 2014 and November 2014...
March 8, 2016: Chinese Journal of Cancer
journal
journal
42277
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"